CEDAR KNOLLS, N.J. and WILMINGTON, N.C., April 6, 2009 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (Nasdaq:EMIS), a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and nutritional supplements using its Eligen(r) Technology, and AAIPharma, Inc. announce a strategic alliance intended to expand the application of Emisphere’s Eligen(r) Technology and AAIPharma’s drug development services.
